The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biological Excipient Market Research Report 2025
Synopsis
Biologic excipients are compounds excluding the pharmacologically active drug component that are used in the synthesis of biologic drugs or are found in the dosage form of a finished pharmaceutical product. They help with formulation design and have a variety of functions, including boosting flow ability, improving flow ability, and increasing compressibility. The biologic excipients market is developing due to rising demand for prolonged or sustained-release formulations and increasing demand for biologic excipients. During the projected period, growing regulatory stringency regarding medication and excipient approval is expected to restrain the market's growth. Patient safety is dependent on the quality of pharmaceutical excipients throughout their life cycle. Low-quality excipients' effects, such as decreased API solubility, have enhanced the necessity of managing many parts of the excipient life cycle, such as design, production and transportation.
Global Biological Excipient market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biological Excipient market research.
Key manufacturers engaged in the Biological Excipient industry include Ashland Inc., BASF Corporation, Colorcon Inc., Evonik Industries, FMC Corporation, The Archer Daniels Midland Company, The Dow Chemical Company, Wacker Chemie AG. and Merck KGaA, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Biological Excipient were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biological Excipient market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biological Excipient market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Ashland Inc.
BASF Corporation
Colorcon Inc.
Evonik Industries
FMC Corporation
The Archer Daniels Midland Company
The Dow Chemical Company
Wacker Chemie AG.
Merck KGaA
Colorcon
Associated British Foods plc
Signet Excipients Pvt. Ltd (IMCD)
Sigachi Industries Limited
Spectrum Chemical Manufacturing Corp.
IMCD
Clariant
Segment by Type
Oral
Topical
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Biological Excipient report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Biologic excipients are compounds excluding the pharmacologically active drug component that are used in the synthesis of biologic drugs or are found in the dosage form of a finished pharmaceutical product. They help with formulation design and have a variety of functions, including boosting flow ability, improving flow ability, and increasing compressibility. The biologic excipients market is developing due to rising demand for prolonged or sustained-release formulations and increasing demand for biologic excipients. During the projected period, growing regulatory stringency regarding medication and excipient approval is expected to restrain the market's growth. Patient safety is dependent on the quality of pharmaceutical excipients throughout their life cycle. Low-quality excipients' effects, such as decreased API solubility, have enhanced the necessity of managing many parts of the excipient life cycle, such as design, production and transportation.
Global Biological Excipient market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biological Excipient market research.
Key manufacturers engaged in the Biological Excipient industry include Ashland Inc., BASF Corporation, Colorcon Inc., Evonik Industries, FMC Corporation, The Archer Daniels Midland Company, The Dow Chemical Company, Wacker Chemie AG. and Merck KGaA, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Biological Excipient were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biological Excipient market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biological Excipient market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Ashland Inc.
BASF Corporation
Colorcon Inc.
Evonik Industries
FMC Corporation
The Archer Daniels Midland Company
The Dow Chemical Company
Wacker Chemie AG.
Merck KGaA
Colorcon
Associated British Foods plc
Signet Excipients Pvt. Ltd (IMCD)
Sigachi Industries Limited
Spectrum Chemical Manufacturing Corp.
IMCD
Clariant
Segment by Type
Oral
Topical
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Biological Excipient report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Biological Excipient Market Overview
1.1 Product Overview and Scope of Biological Excipient
1.2 Biological Excipient Segment by Type
1.2.1 Global Biological Excipient Market Value Comparison by Type (2023-2029)
1.2.2 Oral
1.2.3 Topical
1.3 Biological Excipient Segment by Application
1.3.1 Global Biological Excipient Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Biological Excipient Market Size Estimates and Forecasts
1.4.1 Global Biological Excipient Revenue 2018-2029
1.4.2 Global Biological Excipient Sales 2018-2029
1.4.3 Global Biological Excipient Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Biological Excipient Market Competition by Manufacturers
2.1 Global Biological Excipient Sales Market Share by Manufacturers (2018-2023)
2.2 Global Biological Excipient Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Biological Excipient Average Price by Manufacturers (2018-2023)
2.4 Global Biological Excipient Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Biological Excipient, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biological Excipient, Product Type & Application
2.7 Biological Excipient Market Competitive Situation and Trends
2.7.1 Biological Excipient Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biological Excipient Players Market Share by Revenue
2.7.3 Global Biological Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biological Excipient Retrospective Market Scenario by Region
3.1 Global Biological Excipient Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Biological Excipient Global Biological Excipient Sales by Region: 2018-2029
3.2.1 Global Biological Excipient Sales by Region: 2018-2023
3.2.2 Global Biological Excipient Sales by Region: 2024-2029
3.3 Global Biological Excipient Global Biological Excipient Revenue by Region: 2018-2029
3.3.1 Global Biological Excipient Revenue by Region: 2018-2023
3.3.2 Global Biological Excipient Revenue by Region: 2024-2029
3.4 North America Biological Excipient Market Facts & Figures by Country
3.4.1 North America Biological Excipient Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Biological Excipient Sales by Country (2018-2029)
3.4.3 North America Biological Excipient Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biological Excipient Market Facts & Figures by Country
3.5.1 Europe Biological Excipient Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Biological Excipient Sales by Country (2018-2029)
3.5.3 Europe Biological Excipient Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biological Excipient Market Facts & Figures by Country
3.6.1 Asia Pacific Biological Excipient Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Biological Excipient Sales by Country (2018-2029)
3.6.3 Asia Pacific Biological Excipient Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Biological Excipient Market Facts & Figures by Country
3.7.1 Latin America Biological Excipient Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Biological Excipient Sales by Country (2018-2029)
3.7.3 Latin America Biological Excipient Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biological Excipient Market Facts & Figures by Country
3.8.1 Middle East and Africa Biological Excipient Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Biological Excipient Sales by Country (2018-2029)
3.8.3 Middle East and Africa Biological Excipient Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biological Excipient Sales by Type (2018-2029)
4.1.1 Global Biological Excipient Sales by Type (2018-2023)
4.1.2 Global Biological Excipient Sales by Type (2024-2029)
4.1.3 Global Biological Excipient Sales Market Share by Type (2018-2029)
4.2 Global Biological Excipient Revenue by Type (2018-2029)
4.2.1 Global Biological Excipient Revenue by Type (2018-2023)
4.2.2 Global Biological Excipient Revenue by Type (2024-2029)
4.2.3 Global Biological Excipient Revenue Market Share by Type (2018-2029)
4.3 Global Biological Excipient Price by Type (2018-2029)
5 Segment by Application
5.1 Global Biological Excipient Sales by Application (2018-2029)
5.1.1 Global Biological Excipient Sales by Application (2018-2023)
5.1.2 Global Biological Excipient Sales by Application (2024-2029)
5.1.3 Global Biological Excipient Sales Market Share by Application (2018-2029)
5.2 Global Biological Excipient Revenue by Application (2018-2029)
5.2.1 Global Biological Excipient Revenue by Application (2018-2023)
5.2.2 Global Biological Excipient Revenue by Application (2024-2029)
5.2.3 Global Biological Excipient Revenue Market Share by Application (2018-2029)
5.3 Global Biological Excipient Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Ashland Inc.
6.1.1 Ashland Inc. Corporation Information
6.1.2 Ashland Inc. Description and Business Overview
6.1.3 Ashland Inc. Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Ashland Inc. Biological Excipient Product Portfolio
6.1.5 Ashland Inc. Recent Developments/Updates
6.2 BASF Corporation
6.2.1 BASF Corporation Corporation Information
6.2.2 BASF Corporation Description and Business Overview
6.2.3 BASF Corporation Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BASF Corporation Biological Excipient Product Portfolio
6.2.5 BASF Corporation Recent Developments/Updates
6.3 Colorcon Inc.
6.3.1 Colorcon Inc. Corporation Information
6.3.2 Colorcon Inc. Description and Business Overview
6.3.3 Colorcon Inc. Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Colorcon Inc. Biological Excipient Product Portfolio
6.3.5 Colorcon Inc. Recent Developments/Updates
6.4 Evonik Industries
6.4.1 Evonik Industries Corporation Information
6.4.2 Evonik Industries Description and Business Overview
6.4.3 Evonik Industries Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Evonik Industries Biological Excipient Product Portfolio
6.4.5 Evonik Industries Recent Developments/Updates
6.5 FMC Corporation
6.5.1 FMC Corporation Corporation Information
6.5.2 FMC Corporation Description and Business Overview
6.5.3 FMC Corporation Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.5.4 FMC Corporation Biological Excipient Product Portfolio
6.5.5 FMC Corporation Recent Developments/Updates
6.6 The Archer Daniels Midland Company
6.6.1 The Archer Daniels Midland Company Corporation Information
6.6.2 The Archer Daniels Midland Company Description and Business Overview
6.6.3 The Archer Daniels Midland Company Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.6.4 The Archer Daniels Midland Company Biological Excipient Product Portfolio
6.6.5 The Archer Daniels Midland Company Recent Developments/Updates
6.7 The Dow Chemical Company
6.6.1 The Dow Chemical Company Corporation Information
6.6.2 The Dow Chemical Company Description and Business Overview
6.6.3 The Dow Chemical Company Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.4.4 The Dow Chemical Company Biological Excipient Product Portfolio
6.7.5 The Dow Chemical Company Recent Developments/Updates
6.8 Wacker Chemie AG.
6.8.1 Wacker Chemie AG. Corporation Information
6.8.2 Wacker Chemie AG. Description and Business Overview
6.8.3 Wacker Chemie AG. Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Wacker Chemie AG. Biological Excipient Product Portfolio
6.8.5 Wacker Chemie AG. Recent Developments/Updates
6.9 Merck KGaA
6.9.1 Merck KGaA Corporation Information
6.9.2 Merck KGaA Description and Business Overview
6.9.3 Merck KGaA Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Merck KGaA Biological Excipient Product Portfolio
6.9.5 Merck KGaA Recent Developments/Updates
6.10 Colorcon
6.10.1 Colorcon Corporation Information
6.10.2 Colorcon Description and Business Overview
6.10.3 Colorcon Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Colorcon Biological Excipient Product Portfolio
6.10.5 Colorcon Recent Developments/Updates
6.11 Associated British Foods plc
6.11.1 Associated British Foods plc Corporation Information
6.11.2 Associated British Foods plc Biological Excipient Description and Business Overview
6.11.3 Associated British Foods plc Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Associated British Foods plc Biological Excipient Product Portfolio
6.11.5 Associated British Foods plc Recent Developments/Updates
6.12 Signet Excipients Pvt. Ltd (IMCD)
6.12.1 Signet Excipients Pvt. Ltd (IMCD) Corporation Information
6.12.2 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Description and Business Overview
6.12.3 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Product Portfolio
6.12.5 Signet Excipients Pvt. Ltd (IMCD) Recent Developments/Updates
6.13 Sigachi Industries Limited
6.13.1 Sigachi Industries Limited Corporation Information
6.13.2 Sigachi Industries Limited Biological Excipient Description and Business Overview
6.13.3 Sigachi Industries Limited Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sigachi Industries Limited Biological Excipient Product Portfolio
6.13.5 Sigachi Industries Limited Recent Developments/Updates
6.14 Spectrum Chemical Manufacturing Corp.
6.14.1 Spectrum Chemical Manufacturing Corp. Corporation Information
6.14.2 Spectrum Chemical Manufacturing Corp. Biological Excipient Description and Business Overview
6.14.3 Spectrum Chemical Manufacturing Corp. Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Spectrum Chemical Manufacturing Corp. Biological Excipient Product Portfolio
6.14.5 Spectrum Chemical Manufacturing Corp. Recent Developments/Updates
6.15 IMCD
6.15.1 IMCD Corporation Information
6.15.2 IMCD Biological Excipient Description and Business Overview
6.15.3 IMCD Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.15.4 IMCD Biological Excipient Product Portfolio
6.15.5 IMCD Recent Developments/Updates
6.16 Clariant
6.16.1 Clariant Corporation Information
6.16.2 Clariant Biological Excipient Description and Business Overview
6.16.3 Clariant Biological Excipient Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Clariant Biological Excipient Product Portfolio
6.16.5 Clariant Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biological Excipient Industry Chain Analysis
7.2 Biological Excipient Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biological Excipient Production Mode & Process
7.4 Biological Excipient Sales and Marketing
7.4.1 Biological Excipient Sales Channels
7.4.2 Biological Excipient Distributors
7.5 Biological Excipient Customers
8 Biological Excipient Market Dynamics
8.1 Biological Excipient Industry Trends
8.2 Biological Excipient Market Drivers
8.3 Biological Excipient Market Challenges
8.4 Biological Excipient Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
